![Joerg Alte](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Joerg Alte
Corporate Officer/Principal bei FIDEsprit AG
Aktive Positionen von Joerg Alte
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
FIDEsprit AG | Corporate Officer/Principal | 01.09.2007 | - |
Karriereverlauf von Joerg Alte
Ehemalige bekannte Positionen von Joerg Alte
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SANGUI BIOTECH INTERNATIONAL, INC. | Präsident | 01.11.1998 | 01.04.2000 |
PROTEO, INC. | Direktor/Vorstandsmitglied | 01.01.2000 | - |
Statistik
International
Vereinigte Staaten | 2 |
Deutschland | 2 |
Schweiz | 2 |
Operativ
Director/Board Member | 1 |
President | 1 |
Corporate Officer/Principal | 1 |
Sektoral
Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SANGUI BIOTECH INTERNATIONAL, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Proteo, Inc.
![]() Proteo, Inc. Pharmaceuticals: MajorHealth Technology Proteo, Inc., a clinical stage drug development company, intends to develop, promote, and market pharmaceuticals and other biotech products. The firm focuses on the development of anti-inflammatory treatments for rare diseases. Its proprietary product Elafin, a human protein that naturally occurs in human skin, lungs, and mammary glands. The company's product is intended for the treatment of post-surgery damage to tissue, pulmonary hypertension, serious injuries caused by accidents, cardiac infarction, and other diseases, as well as for the complications resulting from organ transplantation. It has a license and collaboration agreement with ARTES Biotechnology GmbH to produce Elafin by using the sublicensed yeast HANSENULA POLYMORPHA. The company was founded by Oliver Wiedow and Birge Bargmann on December 18, 1992 and is headquartered in Irvine, CA. | Health Technology |
FIDEsprit AG |
- Börse
- Insiders
- Joerg Alte
- Erfahrung